Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin

Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin Xiao-Nan Li 1 , 2 , 3 , Jun Song 1 , 2 , 3 , Lin Zhang 1 , 2 , Scott A. LeMaire 1 , 2 , Xiaoyang Hou 1 , 2 , 3 , Cheng Zhang 1 , 2 , 3 , Joseph S. Coselli 1 ,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2009-10, Vol.58 (10), p.2246-2257
Hauptverfasser: Li, Xiao-Nan, Song, Jun, Zhang, Lin, LeMaire, Scott A, Hou, Xiaoyang, Zhang, Cheng, Coselli, Joseph S, Chen, Li, Wang, Xing Li, Zhang, Yun, Shen, Ying H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2257
container_issue 10
container_start_page 2246
container_title Diabetes (New York, N.Y.)
container_volume 58
creator Li, Xiao-Nan
Song, Jun
Zhang, Lin
LeMaire, Scott A
Hou, Xiaoyang
Zhang, Cheng
Coselli, Joseph S
Chen, Li
Wang, Xing Li
Zhang, Yun
Shen, Ying H
description Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin Xiao-Nan Li 1 , 2 , 3 , Jun Song 1 , 2 , 3 , Lin Zhang 1 , 2 , Scott A. LeMaire 1 , 2 , Xiaoyang Hou 1 , 2 , 3 , Cheng Zhang 1 , 2 , 3 , Joseph S. Coselli 1 , 2 , Li Chen 3 , Xing Li Wang 1 , 2 , Yun Zhang 3 and Ying H. Shen 1 , 2 1 Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; 2 Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas; 3 Qilu Hospital, Shandong University, Jinan, Shandong, China. Corresponding authors: Yun Zhang, zhangyun{at}sdu.edu.cn , and Ying H. Shen, hyshen{at}bcm.edu . X.-N.L. and J.S. contributed equally to this study. Abstract OBJECTIVE Oxidative stress induced by free fatty acids contributes to the development of cardiovascular diseases in patients with metabolic syndrome. Reducing oxidative stress may attenuate these pathogenic processes. Activation of AMP-activated protein kinase (AMPK) has been reported to reduce intracellular reactive oxygen species (ROS) levels. The thioredoxin (Trx) system is a major antioxidant system. In this study, we investigated the mechanisms involved in the AMPK-mediated regulation of Trx expression and the reduction of intracellular ROS levels. RESEARCH DESIGN AND METHODS We observed that activation of AMPK by 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) significantly reduced ROS levels induced by palmitic acid in human aortic endothelial cells. Activation of AMPK increased expression of the antioxidant Trx, which mediated the ROS reduction. RT-PCR showed that AMPK regulated Trx at the transcriptional level. RESULTS Forkhead transcription factor 3 (FOXO3) was identified as the target transcription factor involved in the upregulation of Trx expression. FOXO3 bound to the Trx promoter, recruited the histone acetylase p300 to the Trx promoter, and formed a transcription activator complex, which was enhanced by AICAR treatment. AMPK activated FOXO3 by promoting its nuclear translocation. We further showed that AICAR injection increased the expression of Trx and decreased ROS production in the aortic wall of ApoE−/− mice fed a high-fat diet. CONCLUSIONS These results suggest that activation of the AMPK-FOXO3 pathway reduces ROS levels by inducing Trx expression. Thus, the AMPK-FOXO3-Trx axis may be an important defense mechanism against excessive ROS production induce
doi_str_mv 10.2337/db08-1512
format Article
fullrecord <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A209234965</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A209234965</galeid><sourcerecordid>A209234965</sourcerecordid><originalsourceid>FETCH-LOGICAL-c680t-60e56f76290700a30543b83d9e7c96824f0e0890e5a24906e2f51457adfb08973</originalsourceid><addsrcrecordid>eNp9ksGO0zAQhiMEYsvCgRdAFpyQyOLYiRNfVqoqulQUdQW70t4s15kkXqVxsZ3d9sYbcOANeRIcWrFUqtAcPBp_83v0e6LoZYLPCKX5-3KJizjJEvIoGiWc8piS_OZxNMI4IXGS8_wkeubcLcaYhXganSQ844QlxSj6MVZe30mvTYdMhXwDaPz58lM8XdwsKLqUvrmXW_QFyl6BQ1Pp_RaNlS5_ff8564ZiiWadsiAdIN2F3FupoG37VtrQJgd1QIvNtoYOfV2D0kFmuUXXawt1gLzuanTVaGOhNBvdPY-eVLJ18GJ_nkbX0w9Xk4_xfHExm4znsWIF9jHDkLEqZ4TjHGNJcZbSZUFLDrnirCBphQEXPFCSpBwzIFWWpFkuyyp4xXN6Gp3vdNf9cgWlgmHwVqytXkm7FUZqcXjT6UbU5k6QPMOEsiDwei9gzbcenBe3prddmFmQhKVFnrIBerODatmC0F1lBntW2ikxJpgTmnKWBSo-QgXDIDxsOqh0KB_wZ0f4ECWstDra8PagITAeNr6WvXOiuJj_b5g9q0zbQg0ifMJkcVRbWeOcheqvhwkWw3aKYTvFsJ2BffWv6Q_kfh0D8G4HNLpu7rUFUWq5BA_uIcmKP8okZfQ3zlXssA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216487466</pqid></control><display><type>article</type><title>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Li, Xiao-Nan ; Song, Jun ; Zhang, Lin ; LeMaire, Scott A ; Hou, Xiaoyang ; Zhang, Cheng ; Coselli, Joseph S ; Chen, Li ; Wang, Xing Li ; Zhang, Yun ; Shen, Ying H</creator><creatorcontrib>Li, Xiao-Nan ; Song, Jun ; Zhang, Lin ; LeMaire, Scott A ; Hou, Xiaoyang ; Zhang, Cheng ; Coselli, Joseph S ; Chen, Li ; Wang, Xing Li ; Zhang, Yun ; Shen, Ying H</creatorcontrib><description>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin Xiao-Nan Li 1 , 2 , 3 , Jun Song 1 , 2 , 3 , Lin Zhang 1 , 2 , Scott A. LeMaire 1 , 2 , Xiaoyang Hou 1 , 2 , 3 , Cheng Zhang 1 , 2 , 3 , Joseph S. Coselli 1 , 2 , Li Chen 3 , Xing Li Wang 1 , 2 , Yun Zhang 3 and Ying H. Shen 1 , 2 1 Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; 2 Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas; 3 Qilu Hospital, Shandong University, Jinan, Shandong, China. Corresponding authors: Yun Zhang, zhangyun{at}sdu.edu.cn , and Ying H. Shen, hyshen{at}bcm.edu . X.-N.L. and J.S. contributed equally to this study. Abstract OBJECTIVE Oxidative stress induced by free fatty acids contributes to the development of cardiovascular diseases in patients with metabolic syndrome. Reducing oxidative stress may attenuate these pathogenic processes. Activation of AMP-activated protein kinase (AMPK) has been reported to reduce intracellular reactive oxygen species (ROS) levels. The thioredoxin (Trx) system is a major antioxidant system. In this study, we investigated the mechanisms involved in the AMPK-mediated regulation of Trx expression and the reduction of intracellular ROS levels. RESEARCH DESIGN AND METHODS We observed that activation of AMPK by 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) significantly reduced ROS levels induced by palmitic acid in human aortic endothelial cells. Activation of AMPK increased expression of the antioxidant Trx, which mediated the ROS reduction. RT-PCR showed that AMPK regulated Trx at the transcriptional level. RESULTS Forkhead transcription factor 3 (FOXO3) was identified as the target transcription factor involved in the upregulation of Trx expression. FOXO3 bound to the Trx promoter, recruited the histone acetylase p300 to the Trx promoter, and formed a transcription activator complex, which was enhanced by AICAR treatment. AMPK activated FOXO3 by promoting its nuclear translocation. We further showed that AICAR injection increased the expression of Trx and decreased ROS production in the aortic wall of ApoE−/− mice fed a high-fat diet. CONCLUSIONS These results suggest that activation of the AMPK-FOXO3 pathway reduces ROS levels by inducing Trx expression. Thus, the AMPK-FOXO3-Trx axis may be an important defense mechanism against excessive ROS production induced by metabolic stress and could be a therapeutic target in treating cardiovascular diseases in metabolic syndrome. Footnotes The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Received October 31, 2008. Accepted June 28, 2009. © 2009 by the American Diabetes Association.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db08-1512</identifier><identifier>PMID: 19592618</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Aminoimidazole Carboxamide - analogs &amp; derivatives ; Aminoimidazole Carboxamide - pharmacology ; AMP-Activated Protein Kinases - metabolism ; Animals ; Antioxidants ; Aorta ; Apolipoproteins E - deficiency ; Apolipoproteins E - genetics ; Cardiovascular diseases ; Cardiovascular system ; Care and treatment ; Causes of ; DNA Primers ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - metabolism ; Fatty acids ; Fatty Acids - pharmacology ; Forkhead Box Protein O3 ; Forkhead Transcription Factors - metabolism ; Genetic aspects ; Growth factors ; Humans ; Kinases ; Male ; Metabolic syndrome ; Mice ; Mice, Knockout ; Original ; Oxidative stress ; Palmitic Acid - pharmacology ; Physiological aspects ; Plasmids - drug effects ; Quantitative analysis ; Reactive Oxygen Species - metabolism ; Research design ; Reverse Transcriptase Polymerase Chain Reaction ; Ribonucleotides - pharmacology ; Risk factors ; RNA, Messenger - genetics ; RNA, Small Interfering - genetics ; Thioredoxin ; Thioredoxins ; Thioredoxins - genetics ; Transcription factors ; Up-Regulation</subject><ispartof>Diabetes (New York, N.Y.), 2009-10, Vol.58 (10), p.2246-2257</ispartof><rights>COPYRIGHT 2009 American Diabetes Association</rights><rights>Copyright American Diabetes Association Oct 2009</rights><rights>2009 by the American Diabetes Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c680t-60e56f76290700a30543b83d9e7c96824f0e0890e5a24906e2f51457adfb08973</citedby><cites>FETCH-LOGICAL-c680t-60e56f76290700a30543b83d9e7c96824f0e0890e5a24906e2f51457adfb08973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750236/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750236/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19592618$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Xiao-Nan</creatorcontrib><creatorcontrib>Song, Jun</creatorcontrib><creatorcontrib>Zhang, Lin</creatorcontrib><creatorcontrib>LeMaire, Scott A</creatorcontrib><creatorcontrib>Hou, Xiaoyang</creatorcontrib><creatorcontrib>Zhang, Cheng</creatorcontrib><creatorcontrib>Coselli, Joseph S</creatorcontrib><creatorcontrib>Chen, Li</creatorcontrib><creatorcontrib>Wang, Xing Li</creatorcontrib><creatorcontrib>Zhang, Yun</creatorcontrib><creatorcontrib>Shen, Ying H</creatorcontrib><title>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin Xiao-Nan Li 1 , 2 , 3 , Jun Song 1 , 2 , 3 , Lin Zhang 1 , 2 , Scott A. LeMaire 1 , 2 , Xiaoyang Hou 1 , 2 , 3 , Cheng Zhang 1 , 2 , 3 , Joseph S. Coselli 1 , 2 , Li Chen 3 , Xing Li Wang 1 , 2 , Yun Zhang 3 and Ying H. Shen 1 , 2 1 Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; 2 Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas; 3 Qilu Hospital, Shandong University, Jinan, Shandong, China. Corresponding authors: Yun Zhang, zhangyun{at}sdu.edu.cn , and Ying H. Shen, hyshen{at}bcm.edu . X.-N.L. and J.S. contributed equally to this study. Abstract OBJECTIVE Oxidative stress induced by free fatty acids contributes to the development of cardiovascular diseases in patients with metabolic syndrome. Reducing oxidative stress may attenuate these pathogenic processes. Activation of AMP-activated protein kinase (AMPK) has been reported to reduce intracellular reactive oxygen species (ROS) levels. The thioredoxin (Trx) system is a major antioxidant system. In this study, we investigated the mechanisms involved in the AMPK-mediated regulation of Trx expression and the reduction of intracellular ROS levels. RESEARCH DESIGN AND METHODS We observed that activation of AMPK by 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) significantly reduced ROS levels induced by palmitic acid in human aortic endothelial cells. Activation of AMPK increased expression of the antioxidant Trx, which mediated the ROS reduction. RT-PCR showed that AMPK regulated Trx at the transcriptional level. RESULTS Forkhead transcription factor 3 (FOXO3) was identified as the target transcription factor involved in the upregulation of Trx expression. FOXO3 bound to the Trx promoter, recruited the histone acetylase p300 to the Trx promoter, and formed a transcription activator complex, which was enhanced by AICAR treatment. AMPK activated FOXO3 by promoting its nuclear translocation. We further showed that AICAR injection increased the expression of Trx and decreased ROS production in the aortic wall of ApoE−/− mice fed a high-fat diet. CONCLUSIONS These results suggest that activation of the AMPK-FOXO3 pathway reduces ROS levels by inducing Trx expression. Thus, the AMPK-FOXO3-Trx axis may be an important defense mechanism against excessive ROS production induced by metabolic stress and could be a therapeutic target in treating cardiovascular diseases in metabolic syndrome. Footnotes The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Received October 31, 2008. Accepted June 28, 2009. © 2009 by the American Diabetes Association.</description><subject>Aminoimidazole Carboxamide - analogs &amp; derivatives</subject><subject>Aminoimidazole Carboxamide - pharmacology</subject><subject>AMP-Activated Protein Kinases - metabolism</subject><subject>Animals</subject><subject>Antioxidants</subject><subject>Aorta</subject><subject>Apolipoproteins E - deficiency</subject><subject>Apolipoproteins E - genetics</subject><subject>Cardiovascular diseases</subject><subject>Cardiovascular system</subject><subject>Care and treatment</subject><subject>Causes of</subject><subject>DNA Primers</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - metabolism</subject><subject>Fatty acids</subject><subject>Fatty Acids - pharmacology</subject><subject>Forkhead Box Protein O3</subject><subject>Forkhead Transcription Factors - metabolism</subject><subject>Genetic aspects</subject><subject>Growth factors</subject><subject>Humans</subject><subject>Kinases</subject><subject>Male</subject><subject>Metabolic syndrome</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Original</subject><subject>Oxidative stress</subject><subject>Palmitic Acid - pharmacology</subject><subject>Physiological aspects</subject><subject>Plasmids - drug effects</subject><subject>Quantitative analysis</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Research design</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Ribonucleotides - pharmacology</subject><subject>Risk factors</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Small Interfering - genetics</subject><subject>Thioredoxin</subject><subject>Thioredoxins</subject><subject>Thioredoxins - genetics</subject><subject>Transcription factors</subject><subject>Up-Regulation</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9ksGO0zAQhiMEYsvCgRdAFpyQyOLYiRNfVqoqulQUdQW70t4s15kkXqVxsZ3d9sYbcOANeRIcWrFUqtAcPBp_83v0e6LoZYLPCKX5-3KJizjJEvIoGiWc8piS_OZxNMI4IXGS8_wkeubcLcaYhXganSQ844QlxSj6MVZe30mvTYdMhXwDaPz58lM8XdwsKLqUvrmXW_QFyl6BQ1Pp_RaNlS5_ff8564ZiiWadsiAdIN2F3FupoG37VtrQJgd1QIvNtoYOfV2D0kFmuUXXawt1gLzuanTVaGOhNBvdPY-eVLJ18GJ_nkbX0w9Xk4_xfHExm4znsWIF9jHDkLEqZ4TjHGNJcZbSZUFLDrnirCBphQEXPFCSpBwzIFWWpFkuyyp4xXN6Gp3vdNf9cgWlgmHwVqytXkm7FUZqcXjT6UbU5k6QPMOEsiDwei9gzbcenBe3prddmFmQhKVFnrIBerODatmC0F1lBntW2ikxJpgTmnKWBSo-QgXDIDxsOqh0KB_wZ0f4ECWstDra8PagITAeNr6WvXOiuJj_b5g9q0zbQg0ifMJkcVRbWeOcheqvhwkWw3aKYTvFsJ2BffWv6Q_kfh0D8G4HNLpu7rUFUWq5BA_uIcmKP8okZfQ3zlXssA</recordid><startdate>20091001</startdate><enddate>20091001</enddate><creator>Li, Xiao-Nan</creator><creator>Song, Jun</creator><creator>Zhang, Lin</creator><creator>LeMaire, Scott A</creator><creator>Hou, Xiaoyang</creator><creator>Zhang, Cheng</creator><creator>Coselli, Joseph S</creator><creator>Chen, Li</creator><creator>Wang, Xing Li</creator><creator>Zhang, Yun</creator><creator>Shen, Ying H</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>5PM</scope></search><sort><creationdate>20091001</creationdate><title>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin</title><author>Li, Xiao-Nan ; Song, Jun ; Zhang, Lin ; LeMaire, Scott A ; Hou, Xiaoyang ; Zhang, Cheng ; Coselli, Joseph S ; Chen, Li ; Wang, Xing Li ; Zhang, Yun ; Shen, Ying H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c680t-60e56f76290700a30543b83d9e7c96824f0e0890e5a24906e2f51457adfb08973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Aminoimidazole Carboxamide - analogs &amp; derivatives</topic><topic>Aminoimidazole Carboxamide - pharmacology</topic><topic>AMP-Activated Protein Kinases - metabolism</topic><topic>Animals</topic><topic>Antioxidants</topic><topic>Aorta</topic><topic>Apolipoproteins E - deficiency</topic><topic>Apolipoproteins E - genetics</topic><topic>Cardiovascular diseases</topic><topic>Cardiovascular system</topic><topic>Care and treatment</topic><topic>Causes of</topic><topic>DNA Primers</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - metabolism</topic><topic>Fatty acids</topic><topic>Fatty Acids - pharmacology</topic><topic>Forkhead Box Protein O3</topic><topic>Forkhead Transcription Factors - metabolism</topic><topic>Genetic aspects</topic><topic>Growth factors</topic><topic>Humans</topic><topic>Kinases</topic><topic>Male</topic><topic>Metabolic syndrome</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Original</topic><topic>Oxidative stress</topic><topic>Palmitic Acid - pharmacology</topic><topic>Physiological aspects</topic><topic>Plasmids - drug effects</topic><topic>Quantitative analysis</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Research design</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Ribonucleotides - pharmacology</topic><topic>Risk factors</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Small Interfering - genetics</topic><topic>Thioredoxin</topic><topic>Thioredoxins</topic><topic>Thioredoxins - genetics</topic><topic>Transcription factors</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Xiao-Nan</creatorcontrib><creatorcontrib>Song, Jun</creatorcontrib><creatorcontrib>Zhang, Lin</creatorcontrib><creatorcontrib>LeMaire, Scott A</creatorcontrib><creatorcontrib>Hou, Xiaoyang</creatorcontrib><creatorcontrib>Zhang, Cheng</creatorcontrib><creatorcontrib>Coselli, Joseph S</creatorcontrib><creatorcontrib>Chen, Li</creatorcontrib><creatorcontrib>Wang, Xing Li</creatorcontrib><creatorcontrib>Zhang, Yun</creatorcontrib><creatorcontrib>Shen, Ying H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Xiao-Nan</au><au>Song, Jun</au><au>Zhang, Lin</au><au>LeMaire, Scott A</au><au>Hou, Xiaoyang</au><au>Zhang, Cheng</au><au>Coselli, Joseph S</au><au>Chen, Li</au><au>Wang, Xing Li</au><au>Zhang, Yun</au><au>Shen, Ying H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2009-10-01</date><risdate>2009</risdate><volume>58</volume><issue>10</issue><spage>2246</spage><epage>2257</epage><pages>2246-2257</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin Xiao-Nan Li 1 , 2 , 3 , Jun Song 1 , 2 , 3 , Lin Zhang 1 , 2 , Scott A. LeMaire 1 , 2 , Xiaoyang Hou 1 , 2 , 3 , Cheng Zhang 1 , 2 , 3 , Joseph S. Coselli 1 , 2 , Li Chen 3 , Xing Li Wang 1 , 2 , Yun Zhang 3 and Ying H. Shen 1 , 2 1 Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; 2 Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas; 3 Qilu Hospital, Shandong University, Jinan, Shandong, China. Corresponding authors: Yun Zhang, zhangyun{at}sdu.edu.cn , and Ying H. Shen, hyshen{at}bcm.edu . X.-N.L. and J.S. contributed equally to this study. Abstract OBJECTIVE Oxidative stress induced by free fatty acids contributes to the development of cardiovascular diseases in patients with metabolic syndrome. Reducing oxidative stress may attenuate these pathogenic processes. Activation of AMP-activated protein kinase (AMPK) has been reported to reduce intracellular reactive oxygen species (ROS) levels. The thioredoxin (Trx) system is a major antioxidant system. In this study, we investigated the mechanisms involved in the AMPK-mediated regulation of Trx expression and the reduction of intracellular ROS levels. RESEARCH DESIGN AND METHODS We observed that activation of AMPK by 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) significantly reduced ROS levels induced by palmitic acid in human aortic endothelial cells. Activation of AMPK increased expression of the antioxidant Trx, which mediated the ROS reduction. RT-PCR showed that AMPK regulated Trx at the transcriptional level. RESULTS Forkhead transcription factor 3 (FOXO3) was identified as the target transcription factor involved in the upregulation of Trx expression. FOXO3 bound to the Trx promoter, recruited the histone acetylase p300 to the Trx promoter, and formed a transcription activator complex, which was enhanced by AICAR treatment. AMPK activated FOXO3 by promoting its nuclear translocation. We further showed that AICAR injection increased the expression of Trx and decreased ROS production in the aortic wall of ApoE−/− mice fed a high-fat diet. CONCLUSIONS These results suggest that activation of the AMPK-FOXO3 pathway reduces ROS levels by inducing Trx expression. Thus, the AMPK-FOXO3-Trx axis may be an important defense mechanism against excessive ROS production induced by metabolic stress and could be a therapeutic target in treating cardiovascular diseases in metabolic syndrome. Footnotes The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Received October 31, 2008. Accepted June 28, 2009. © 2009 by the American Diabetes Association.</abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>19592618</pmid><doi>10.2337/db08-1512</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2009-10, Vol.58 (10), p.2246-2257
issn 0012-1797
1939-327X
language eng
recordid cdi_gale_infotracmisc_A209234965
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Aminoimidazole Carboxamide - analogs & derivatives
Aminoimidazole Carboxamide - pharmacology
AMP-Activated Protein Kinases - metabolism
Animals
Antioxidants
Aorta
Apolipoproteins E - deficiency
Apolipoproteins E - genetics
Cardiovascular diseases
Cardiovascular system
Care and treatment
Causes of
DNA Primers
Endothelium, Vascular - drug effects
Endothelium, Vascular - metabolism
Fatty acids
Fatty Acids - pharmacology
Forkhead Box Protein O3
Forkhead Transcription Factors - metabolism
Genetic aspects
Growth factors
Humans
Kinases
Male
Metabolic syndrome
Mice
Mice, Knockout
Original
Oxidative stress
Palmitic Acid - pharmacology
Physiological aspects
Plasmids - drug effects
Quantitative analysis
Reactive Oxygen Species - metabolism
Research design
Reverse Transcriptase Polymerase Chain Reaction
Ribonucleotides - pharmacology
Risk factors
RNA, Messenger - genetics
RNA, Small Interfering - genetics
Thioredoxin
Thioredoxins
Thioredoxins - genetics
Transcription factors
Up-Regulation
title Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T06%3A17%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20the%20AMPK-FOXO3%20Pathway%20Reduces%20Fatty%20Acid%E2%80%93Induced%20Increase%20in%20Intracellular%20Reactive%20Oxygen%20Species%20by%20Upregulating%20Thioredoxin&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=Li,%20Xiao-Nan&rft.date=2009-10-01&rft.volume=58&rft.issue=10&rft.spage=2246&rft.epage=2257&rft.pages=2246-2257&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/db08-1512&rft_dat=%3Cgale_cross%3EA209234965%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216487466&rft_id=info:pmid/19592618&rft_galeid=A209234965&rfr_iscdi=true